Bucol, Sarah Jane C.

HRN: 16-06-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2025
CEFUROXIME 750MG (VIAL)
11/19/2025
11/26/2025
IV
750mg
Q 8 Hours
Presumptive PTB
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  PneumoniaURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: